Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake.

Cheng Q, Wållberg H, Grafström J, Lu L, Thorell JO, Hägg Olofsson M, Linder S, Johansson K, Tegnebratt T, Arnér ES, Stone-Elander S, Ahlzén HS, Ståhl S; Sel-tag imaging project.

EJNMMI Res. 2016 Dec;6(1):58. doi: 10.1186/s13550-016-0213-8. Epub 2016 Jul 7.

2.

Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.

Velikyan I, Wennborg A, Feldwisch J, Lindman H, Carlsson J, Sörensen J.

Am J Nucl Med Mol Imaging. 2016 Apr 24;6(2):135-53. eCollection 2016.

3.

iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties.

Šácha P, Knedlík T, Schimer J, Tykvart J, Parolek J, Navrátil V, Dvořáková P, Sedlák F, Ulbrich K, Strohalm J, Majer P, Šubr V, Konvalinka J.

Angew Chem Int Ed Engl. 2016 Feb 12;55(7):2356-60. doi: 10.1002/anie.201508642. Epub 2016 Jan 8.

4.

Extremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein Scaffold.

Lomonosova AV, Ovchinnikova EV, Kazakov AS, Denesyuk AI, Sofin AD, Mikhailov RV, Ulitin AB, Mirzabekov TA, Permyakov EA, Permyakov SE.

PLoS One. 2015 Aug 6;10(8):e0134906. doi: 10.1371/journal.pone.0134906. eCollection 2015.

5.

Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process.

Houlihan G, Gatti-Lafranconi P, Lowe D, Hollfelder F.

Protein Eng Des Sel. 2015 Sep;28(9):269-79. doi: 10.1093/protein/gzv029. Epub 2015 Jun 30.

6.

Nanobodies and recombinant binders in cell biology.

Helma J, Cardoso MC, Muyldermans S, Leonhardt H.

J Cell Biol. 2015 Jun 8;209(5):633-44. doi: 10.1083/jcb.201409074. Review.

7.

Intra-domain phage display (ID-PhD) of peptides and protein mini-domains censored from canonical pIII phage display.

Tjhung KF, Deiss F, Tran J, Chou Y, Derda R.

Front Microbiol. 2015 Apr 28;6:340. doi: 10.3389/fmicb.2015.00340. eCollection 2015.

8.

Peptide aptamers: development and applications.

Reverdatto S, Burz DS, Shekhtman A.

Curr Top Med Chem. 2015;15(12):1082-101. Review.

9.

Engineering tandem single-chain Fv as cell surface reporters with enhanced properties of fluorescence detection.

Gallo E, Snyder AC, Jarvik JW.

Protein Eng Des Sel. 2015 Oct;28(10):327-37. doi: 10.1093/protein/gzv016. Epub 2015 Apr 5.

PMID:
25843939
10.

Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.

Checco JW, Kreitler DF, Thomas NC, Belair DG, Rettko NJ, Murphy WL, Forest KT, Gellman SH.

Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4552-7. doi: 10.1073/pnas.1420380112. Epub 2015 Mar 30.

11.

Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics.

Sand KM, Bern M, Nilsen J, Noordzij HT, Sandlie I, Andersen JT.

Front Immunol. 2015 Jan 26;5:682. doi: 10.3389/fimmu.2014.00682. eCollection 2014. Review.

12.
13.

Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently.

Currin A, Swainston N, Day PJ, Kell DB.

Chem Soc Rev. 2015 Mar 7;44(5):1172-239. doi: 10.1039/c4cs00351a. Review.

14.

An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo.

Yu F, Gudmundsdotter L, Akal A, Gunneriusson E, Frejd F, Nygren PÅ.

MAbs. 2014;6(6):1598-607. doi: 10.4161/mabs.36089.

15.

An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein.

Seijsing J, Lindborg M, Höidén-Guthenberg I, Bönisch H, Guneriusson E, Frejd FY, Abrahmsén L, Ekblad C, Löfblom J, Uhlén M, Gräslund T.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17110-5. doi: 10.1073/pnas.1417717111. Epub 2014 Nov 18.

16.

Tethered protein display identifies a novel Kir3.2 (GIRK2) regulator from protein scaffold libraries.

Bagriantsev SN, Chatelain FC, Clark KA, Alagem N, Reuveny E, Minor DL Jr.

ACS Chem Neurosci. 2014 Sep 17;5(9):812-22. doi: 10.1021/cn5000698. Epub 2014 Jul 16.

17.

Tetraspecific ligand for tumor-targeted delivery of nanomaterials.

Kim D, Friedman AD, Liu R.

Biomaterials. 2014 Jul;35(23):6026-36. doi: 10.1016/j.biomaterials.2014.04.015. Epub 2014 Apr 28.

18.

Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells.

Kuchař M, Vaňková L, Petroková H, Cerný J, Osička R, Pelák O, Sípová H, Schneider B, Homola J, Sebo P, Kalina T, Malý P.

Proteins. 2014 Jun;82(6):975-89. doi: 10.1002/prot.24472. Epub 2013 Nov 23.

19.

Tracking molecular recognition at the atomic level with a new protein scaffold based on the OB-fold.

Steemson JD, Baake M, Rakonjac J, Arcus VL, Liddament MT.

PLoS One. 2014 Jan 20;9(1):e86050. doi: 10.1371/journal.pone.0086050. eCollection 2014.

20.

Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents.

Qiao J, Xue S, Pu F, White N, Jiang J, Liu ZR, Yang JJ.

J Biol Inorg Chem. 2014 Feb;19(2):259-70. doi: 10.1007/s00775-013-1076-3. Epub 2013 Dec 24. Review.

Items per page

Supplemental Content

Write to the Help Desk